These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6587753)

  • 1. Pharmacokinetics of calcium blockers in patients with renal insufficiency and in geriatric patients.
    Storstein L; Larsen A; Midtbø K; Saevareid L
    Acta Med Scand Suppl; 1984; 681():25-30. PubMed ID: 6587753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium antagonists. Pharmacokinetic properties.
    Kates RE
    Drugs; 1983 Feb; 25(2):113-24. PubMed ID: 6339196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of verapamil, nifedipine and diltiazem.
    Echizen H; Eichelbaum M
    Clin Pharmacokinet; 1986; 11(6):425-49. PubMed ID: 3542336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics and dynamics of calcium entry antagonists in systemic hypertension.
    McAllister RG; Schloemer GL; Hamann SR
    Am J Cardiol; 1986 Feb; 57(7):16D-21D. PubMed ID: 3513512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of calcium-entry blockers.
    McAllister RG; Hamann SR; Blouin RA
    Am J Cardiol; 1985 Jan; 55(3):30B-40B. PubMed ID: 3881917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics of racemic verapamil in patients with impaired renal function.
    Zachariah PK; Moyer TP; Theobald HM; Frantz RP; Kurtz SB; McCarthy JT; Smith RL
    J Clin Pharmacol; 1991 Jan; 31(1):45-53. PubMed ID: 2045528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of verapamil in patients with renal failure.
    Mooy J; Schols M; v Baak M; v Hooff M; Muytjens A; Rahn KH
    Eur J Clin Pharmacol; 1985; 28(4):405-10. PubMed ID: 4029246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of verapamil, diltiazem, and nifedipine on plasma levels and renal excretion of digitoxin.
    Kuhlmann J
    Clin Pharmacol Ther; 1985 Dec; 38(6):667-73. PubMed ID: 3905167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of gender on the pharmacokinetics of verapamil and norverapamil in human.
    Dadashzadeh S; Javadian B; Sadeghian S
    Biopharm Drug Dispos; 2006 Oct; 27(7):329-34. PubMed ID: 16892180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verapamil and norverapamil plasma levels in infants and children during chronic oral treatment.
    Piovan D; Padrini R; Svalato Moreolo G; Magnolfi G; Milanesi O; Zordan R; Pellegrino PA; Ferrari M
    Ther Drug Monit; 1995 Feb; 17(1):60-7. PubMed ID: 7725379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of verapamil.
    Hamann SR; Blouin RA; McAllister RG
    Clin Pharmacokinet; 1984; 9(1):26-41. PubMed ID: 6362951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on calcium-channel blocking agents.
    Talbert RL; Bussey HI
    Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of verapamil and its metabolite norverapamil in rats with hyperlipidaemia induced by poloxamer 407.
    Lee YS; Yoon JN; Yoon IS; Lee MG; Kang HE
    Xenobiotica; 2012 Aug; 42(8):766-74. PubMed ID: 22300394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of calcium channel blocking agents.
    Anderson P
    Acta Pharmacol Toxicol (Copenh); 1986; 58 Suppl 2():43-57. PubMed ID: 2940799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of verapamil in patients with hypertension.
    Anderson P; Bondesson U; de Faire U
    Eur J Clin Pharmacol; 1986; 31(2):155-63. PubMed ID: 3803414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of diltiazem and other calcium entry blockers.
    Hermann P; Morselli PL
    Acta Pharmacol Toxicol (Copenh); 1985; 57 Suppl 2():10-20. PubMed ID: 3904330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verapamil kinetics during maintenance hemodialysis.
    Shah GM; Winer RL
    Am J Nephrol; 1985; 5(5):338-41. PubMed ID: 4061502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of verapamil and norverapamil during long-term oral therapy.
    Tartaglione TA; Pieper JA; Lopez LL; Mehta J
    Res Commun Chem Pathol Pharmacol; 1983 Apr; 40(1):15-27. PubMed ID: 6867470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of naringin on the pharmacokinetics of verapamil and one of its metabolites, norverapamil, in rabbits.
    Kim HJ; Choi JS
    Biopharm Drug Dispos; 2005 Oct; 26(7):295-300. PubMed ID: 16013069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced bioavailability of verapamil after oral administration with hesperidin in rats.
    Piao YJ; Choi JS
    Arch Pharm Res; 2008 Apr; 31(4):518-22. PubMed ID: 18449511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.